| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.871 | 3.791 | 2.600 | 8.166 | 8.993 | 11.614 | 27.405 | 44.931 | 52.098 |
| Total Income - EUR | - | 3.871 | 3.793 | 2.600 | 8.166 | 8.993 | 11.614 | 27.405 | 44.931 | 52.098 |
| Total Expenses - EUR | - | 14.524 | 11.177 | 2.908 | 5.883 | 7.286 | 10.880 | 15.254 | 16.896 | 13.016 |
| Gross Profit/Loss - EUR | - | -10.653 | -7.384 | -308 | 2.283 | 1.707 | 734 | 12.151 | 28.035 | 39.081 |
| Net Profit/Loss - EUR | - | -10.780 | -7.501 | -386 | 2.129 | 1.622 | 617 | 11.877 | 27.594 | 38.639 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Bio View Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.680 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 829 |
| Current Assets | - | 2.600 | 577 | 677 | 1.335 | 1.570 | 1.985 | 4.409 | 28.117 | 41.047 |
| Inventories | - | 2.441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 126 | 0 | 61 | 473 | 21.753 | 31.969 |
| Cash | - | 158 | 577 | 677 | 1.209 | 1.570 | 1.924 | 3.936 | 6.364 | 9.078 |
| Shareholders Funds | - | -10.736 | -18.087 | -18.141 | -15.660 | -13.742 | -12.820 | -983 | 26.614 | 38.970 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 15.015 | 18.664 | 18.818 | 16.996 | 15.312 | 14.805 | 5.391 | 1.503 | 2.907 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Bio View Srl